IRIgor da Fonseca Rangel

Igor da Fonseca Rangel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Igor da Fonseca Rangel has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adolescent Exposure to a THC ‐Rich Cannabis Extract Produces Genotype‐Dependent Effects on Cognition and Glial Morphology in Serine Racemase Mutant Mice

    by Igor F. Rangel, Melissa Chaves, Iohanna Pagnoncelli, Isabelle Medeiros, Felipe Pinheiro, Lorena Fortuna, Luiza Castello‐Branco, Ernesto Diaz Roch, Virgínia Martins Carvalho, Flavia Regina Souza Lima, et al.

    Adolescent cannabis exposure has been associated with an increased risk of schizophrenia; however, how genetic vulnerability shapes the long‐term consequences of adolescent cannabinoid exposure remains poorly understood. Δ 9 ‐Tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis and the predominant cannabinoid in the THC‐rich cannabis extract used here, primarily activates cannabinoid type 1 receptors (CB1). In parallel, reduced availability of D‐serine, an endogenous co‐agonist of N‐methyl‐D‐aspartate receptors (NMDARs), has been implicated in the pathophysiology of schizophrenia. Here, we investigated whether adolescent exposure to a THC‐rich cannabis extract modulated long‐term behavioral, neurochemical, and glial outcomes in serine racemase mutant (SrrY269*) mice, a genetic model characterized by reduced D‐serine levels and schizophrenia‐relevant phenotypes. Mice received escalating oral doses of the THC‐rich cannabis extract during adolescence and were evaluated in adulthood using behavioral assays, amino acid quantification, and glial morphometric analyses. Adolescent exposure to the THC‐rich cannabis extract prevented deficits in prepulse inhibition and spatial object recognition memory in adult SrrY269* mice, while transiently impairing sensorimotor gating in wild‐type animals. Irrespective of genotype, mice exposed to the THC‐rich cannabis extract spent more time in the center of the open field in adulthood. In behaviorally tested SrrY269* mice, reduced hippocampal microglial branching was attenuated following adolescent treatment. In an independent behavior‐naïve cohort, SrrY269* mice exhibited marked astrocytic morphological alterations, several of which were also attenuated by adolescent exposure to the THC‐rich cannabis extract. In contrast, the same treatment induced a distinct astrocytic phenotype in wild‐type mice. Adolescent exposure to the THC‐rich cannabis extract did not alter hippocampal or prefrontal cortical levels of D‐serine or other amino acids involved in NMDAR signaling in adulthood. These findings indicate that adolescent exposure to a THC‐rich cannabis extract produces genotype‐dependent long‐term effects, preventing specific behavioral deficits and attenuating independently assessed microglial and astrocytic alterations in SrrY269* mice, while producing adverse behavioral and astrocytic outcomes in wild‐type animals. Genetic background may therefore be an important determinant of the long‐term neurodevelopmental consequences of adolescent exposure to THC‐rich cannabis extracts. image


  • Open Access

    Aseptic Meningitis Due to Spontaneous Rupture of a Multicystic Craniopharyngioma with an Ommaya Catheter: A Case Report

    by Igor da Fonseca Rangel, Ricardo C. Oliveira, Pablo V. B. dos Santos, Renan S. Rodrigues, Carlos R. de Lima, Marcus A. Acioly

    Craniopharyngiomas (CPs) are benign tumors that are believed to arise from embryonic remnants of the Rathke pouch epithelium. Herein, we report a case of aseptic meningitis due to spontaneous rupture of multicystic CP, which contained an Ommaya catheter. A 19-year-old boy was admitted to the hospital with a 4-day history of acute severe headache after strenuous physical exercise followed by altered sensorium, fever, and neck stiffness. Cerebrospinal fluid (CSF) analysis revealed marked pleocytosis and elevated protein levels. CSF culture was otherwise negative. Cyst reduction on subsequent imaging confirmed the diagnosis. The patient received intravenous steroid therapy and was discharged asymptomatic. This is a rare evolution of a multicystic CP, which was previously treated with intracystic therapy and had an Ommaya catheter. Clinicians should be aware of spontaneous CP rupture and look actively for the occurrence of cholesterol crystals or elevated CSF levels of cholesterol as well as prompt follow-up imaging.


  • Thyroid hormone activation by type 2 deiodinase mediates exercise‐induced peroxisome proliferator‐activated receptor‐γ coactivator‐1α expression in skeletal muscle

    by Barbara M. L. C. Bocco, Ruy A. N. Louzada, Diego H. S. Silvestre, Maria C. S. Santos, Elena Anne‐Palmer, Igor F. Rangel, Sherine Abdalla, Andrea C. Ferreira, Miriam O. Ribeiro, Balázs Gereben, et al.

    Key points: In skeletal muscle, physical exercise and thyroid hormone mediate the peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1a) expression that is crucial to skeletal muscle mitochondrial function. The expression of type 2 deiodinase (D2), which activates thyroid hormone in skeletal muscle is upregulated by acute treadmill exercise through a β‐adrenergic receptor‐dependent mechanism. Pharmacological block of D2 or disruption of the Dio2 gene in skeletal muscle fibres impaired acute exercise‐induced PGC‐1a expression. Dio2 disruption also impaired muscle PGC‐1a expression and mitochondrial citrate synthase activity in chronically exercised mice. Thyroid hormone promotes expression of peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1a), which mediates mitochondrial biogenesis and oxidative capacity in skeletal muscle (SKM). Skeletal myocytes express the type 2 deiodinase (D2), which generates 3,5,3′‐triiodothyronine (T3), the active thyroid hormone. To test whether D2‐generated T3 plays a role in exercise‐induced PGC‐1a expression, male rats and mice with SKM‐specific Dio2 inactivation (SKM‐D2KO or MYF5‐D2KO) were studied. An acute treadmill exercise session (20 min at 70–75% of maximal aerobic capacity) increased D2 expression/activity (1.5‐ to 2.7‐fold) as well as PGC‐1a mRNA levels (1.5‐ to 5‐fold) in rat soleus muscle and white gastrocnemius muscle and in mouse soleus muscle, which was prevented by pretreatment with 1 mg (100 g body weight)−1 propranolol or 6 mg (100 g body weight)−1 iopanoic acid (5.9‐ vs. 2.8‐fold; P < 0.05), which blocks D2 activity . In the SKM‐D2KO mice, acute treadmill exercise failed to induce PGC‐1a fully in soleus muscle (1.9‐ vs. 2.8‐fold; P < 0.05), and in primary SKM‐D2KO myocytes there was only a limited PGC‐1a response to 1 μm forskolin (2.2‐ vs. 1.3‐fold; P < 0.05). Chronic exercise training (6 weeks) increased soleus muscle PGC‐1a mRNA levels (∼25%) and the mitochondrial enzyme citrate synthase (∼20%). In contrast, PGC‐1a expression did not change and citrate synthase decreased by ∼30% in SKM‐D2KO mice. The soleus muscle PGC‐1a response to chronic exercise was also blunted in MYF5‐D2KO mice. In conclusion, acute treadmill exercise increases SKM D2 expression through a β‐adrenergic receptor‐dependent mechanism. The accelerated conversion of T4 to T3 within myocytes mediates part of the PGC‐1a induction by treadmill exercise and its downstream effects on mitochondrial function.